Cargando…
Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials
BACKGROUND: Regulatory T lymphocytes (Treg) infiltrate human glioblastoma (GBM); are involved in tumor progression and correlate with tumor grade. Transient elimination of Tregs using CD25 depleting antibodies (PC61) has been found to mediate GBM regression in preclinical models of brain tumors. Cli...
Autores principales: | Curtin, James F., Candolfi, Marianela, Fakhouri, Tamer M., Liu, Chunyan, Alden, Anderson, Edwards, Matthew, Lowenstein, Pedro R., Castro, Maria G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291560/ https://www.ncbi.nlm.nih.gov/pubmed/18431473 http://dx.doi.org/10.1371/journal.pone.0001983 |
Ejemplares similares
-
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
por: Franson, Andrea, et al.
Publicado: (2022) -
In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain
por: Barcia, Carlos, et al.
Publicado: (2006) -
Modeling the Th17 and Tregs Paradigm: Implications for Cancer Immunotherapy
por: Corral-Jara, Karla F., et al.
Publicado: (2021) -
Dendritic Cell-Based Immunotherapy for Glioma: Multiple Regimens and Implications in Clinical Trials
por: Mineharu, Yohei, et al.
Publicado: (2013) -
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
por: Curtin, James F, et al.
Publicado: (2009)